Administration of pentoxifylline to improve anemia of hemodialysis patients

Heshmatolah Shahbazian ¹, Ali Ghorbani ¹, Azita Zafar-Mohtashami ² * , Abdolreza Balali ³, Armaghan AleAli ¹, Gholam Reza Lashkarara ⁴

Cited by CrossRef: 4

1- Xu Y, Xu F, Shen W. The efficacy and safety of pentoxifylline in the treatment of chronic kidney disease: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2026;82(6) [Crossref]

2- Zakaria H, Hamdy N, Sayed-Ahmed N, El-Mallah A. Effect of pentoxifylline on hepcidin and iron profile in hemodialysis patients: A randomized, double-blind, placebo-controlled clinical trial. Medicina Clínica (English Edition). 2025;164(6):263 [Crossref]

3- Elmeazawy R, AbdElsamea M, Barakat A, El Sharaby R, EL-Moazen A, Hamza M, Toema O. Oral pentoxifylline as a novel adjunct to standard therapy in pediatric community-acquired pneumonia: a randomized controlled trial. Pediatr Res. 2026; [Crossref]

4- Zakaria H, Hamdy N, Sayed-Ahmed N, El-Mallah A. Effect of pentoxifylline on hepcidin and iron profile in hemodialysis patients: A randomized, double-blind, placebo-controlled clinical trial. Medicina Clínica. 2025;164(6):263 [Crossref]

5- COŞKUN D, ÇETİN G, ÇORUM O. Keçilere Artan Dozlarda Pentoksifilin Uygulamasının Biyokimyasal ve Hematolojik Parametrelere Etkisi. 2022; [Crossref]

6- Zakaria H, Hamdy N, Sayed-Ahmed N, El-Mallah A. Pentoxifylline improves anemia through its novel effect on hypoxia-inducible factor-2 alpha in hemodialysis patients: a randomized, double-blind, placebo-controlled clinical trial. Postgraduate Medicine. 2024;136(8):847 [Crossref]